Track the Generate Biomedicines, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was filed on 6 March 2026 (Acquisition). Among the most active insiders: Nally Michael. The full history is accessible without an account.
8
Insider Decl.
0
Thresholds
€237,972
4 ops.
Buy Volume
·
0 ops.
Sell Volume
52Σ signal
Buys €237,972· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Generate Biomedicines, Inc. is a biopharmaceutical company focused on developing protein-based therapeutics. It utilizes a protein design platform to create innovative therapies.